Jacob Gottlieb launches Altium Capital

Altium Capital is a high profile company that many people do not know about. The company has just started its journey towards success since Jacob Gottlieb recently launched it. Gottlieb is not a new name in the investment industry. He has been around since 1998 when he joined Wall Street. He specializes in looking for investment opportunities in the healthcare sector. Currently, he is looking for innovations in the industry which are worth investing in. He has already made the first move with the investment in Oramed Pharmaceuticals Inc.

Jacob Gottlieb is doing very well in the field of investments. He was one of the founders of Visium Asset Management. He also served as its chief investment officer. Gottlieb had success with this company in one decade. He created the company with $300 million, but after one decade, it was worth $8 billion. It was such an outstanding achievement that he has made in the industry. The firm had grown into one of the major hedge funds in the healthcare sector. On top, it had over 200 employees. Visium was successful because of the principles which he had installed in the company. He had put in place an approach of bringing in new talent in the investment industry by creating a recruitment process that offered new investors a chance to prove themselves.

Visium Asset Management, unfortunately, closed shop after it was bought down by allegations of misconduct involving some of the executives in the company. Although he was not personally mentioned, he suffered from the closure of the company which mainly happened due to mass withdraw of capital by investors, in one night, over $3 billion was withdrawn, leaving the company with nothing to do. It is believed that even if the company was given a chance, it would have rectified the situation.

He is back with Altium Capital and is hoping to take advantage of the innovative growth which is being recorded by companies in the healthcare sector. Gottlieb has already chosen Oramed Pharmaceuticals as a company worth investing in due to an innovation they have where insulin will not need to be injected into the body. Alternatively, they have created an insulin capsule.